-
WU XiaohuiBeijingSenior AttorneyTel:(86-10) 6892-1000Email:wuxiaohui@wanhuida.comService:Patent / LitigationLanguage:Chinese / English
WU Xiaohui is a senior patent attorney primarily engaged in providing patent legal services in the fields of pharmaceuticals, pesticides, chemicals, and materials. She has represented numerous well-known domestic and international pharmaceutical and chemical companies in handling patent matters and providing professional consulting services. She assists both domestic and international clients with patent invalidation, administrative litigation, civil litigation, and patent administrative enforcement cases. Ms. Wu also formulates patent application strategies and offers legal services such as patent validity analysis, infringement risk assessment, and freedom-to-operate analysis.
Since 2008, Ms. Wu has been working in the patent field and has handled numerous patent administrative litigation and enforcement cases, successfully safeguarding the interests of clients. Ms. Wu has managed several highly influential cases in the industry, which were recognized as model cases by the Supreme People's Court and the China National Intellectual Property Administration.
Peking Union Medical College & Chinese Academy of Medical Sciences, Master in Pharmaceutics
China Pharmaceutical University, Bachelor in Pharmaceutical Chemistry
Patent attorney (qualified both for prosecution and litigation)
- Representing the patent owner to defend its two pharmaceutical use patents before the SPC. The cases were selected as the 50 Typical Intellectual Property Cases in Chinese Courts of 2022.
- Wining two administrative enforcement cases in the fields of pharmaceutical industry before Beijing IP Office and Shanghai IP Office which were selected as the National Ten Exemplary Patent Administrative Enforcement Cases of 2018 and 2019 by the National Intellectual Property Administration, respectively.
- Providing patent infringement risk analysis, patent stability analysis, patent application strategies, and drafting services for numerous domestic and international companies in the pharmaceutical, chemical, and food industries.
- Inventions that appear to be “readily available” are not necessarily obvious--Analysis of Administrative Litigation Cases Involving the Invalidation of L-ornidazole Patent Rights, 2022 China's SPC issues landmark drug patent ruling, Managing Intellectual Property, 2021
- Offering to sell constitutes patent infringement, Managing Intellectual Property, 2019
- Analyzing reasonable protection scope in medical use claims, Managing Intellectual Property, 2019
Co-author the Chinese Translation of “Patent Law (Janice M. Muller, Third Edition)”, which is published by Intellectual Property Publishing House Co., Ltd.